1. Home
  2. OLMA vs SAR Comparison

OLMA vs SAR Comparison

Compare OLMA & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
    SELLHOLDBUYas of 2 days ago
  • SAR
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • OLMA 2006
  • SAR 2007
  • Country
  • OLMA United States
  • SAR United States
  • Employees
  • OLMA N/A
  • SAR N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • SAR Investment Managers
  • Sector
  • OLMA Health Care
  • SAR Finance
  • Exchange
  • OLMA Nasdaq
  • SAR Nasdaq
  • Market Cap
  • OLMA 289.0M
  • SAR 346.8M
  • IPO Year
  • OLMA 2020
  • SAR 2007
  • Fundamental
  • Price
  • OLMA $4.11
  • SAR $25.20
  • Analyst Decision
  • OLMA Strong Buy
  • SAR Buy
  • Analyst Count
  • OLMA 4
  • SAR 4
  • Target Price
  • OLMA $26.75
  • SAR $25.08
  • AVG Volume (30 Days)
  • OLMA 939.7K
  • SAR 122.1K
  • Earning Date
  • OLMA 03-18-2025
  • SAR 05-05-2025
  • Dividend Yield
  • OLMA N/A
  • SAR 13.18%
  • EPS Growth
  • OLMA N/A
  • SAR 33.28
  • EPS
  • OLMA N/A
  • SAR 2.49
  • Revenue
  • OLMA N/A
  • SAR $154,793,533.00
  • Revenue This Year
  • OLMA N/A
  • SAR $6.07
  • Revenue Next Year
  • OLMA N/A
  • SAR N/A
  • P/E Ratio
  • OLMA N/A
  • SAR $10.14
  • Revenue Growth
  • OLMA N/A
  • SAR 11.52
  • 52 Week Low
  • OLMA $3.93
  • SAR $21.56
  • 52 Week High
  • OLMA $16.62
  • SAR $26.49
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 37.74
  • SAR 58.10
  • Support Level
  • OLMA $3.93
  • SAR $23.29
  • Resistance Level
  • OLMA $4.45
  • SAR $25.48
  • Average True Range (ATR)
  • OLMA 0.31
  • SAR 0.39
  • MACD
  • OLMA 0.04
  • SAR 0.16
  • Stochastic Oscillator
  • OLMA 21.95
  • SAR 87.40

Stock Price Comparison Chart: OLMA vs SAR

OLMA
SAR
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250510152025303540OLMA VS SAR

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About SAR Saratoga Investment Corp New

Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use